Asset
Diazepam
Aquestive Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03953820 | phase1_2 | completed | 2019-04-13 | 2019-07-31 | Aquestive Therapeutics | Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study |
| NCT03222349 | phase2 | completed | 2017-08-31 | 2020-01-28 | Aquestive Therapeutics | Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy |
| NCT03428360 | phase3 | completed | 2018-01-23 | 2020-06-25 | Aquestive Therapeutics | Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy |
| NCT03179891 | phase2 | completed | 2017-05-25 | 2018-07-25 | Aquestive Therapeutics | Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy |
FDA applications (2)
| Application | Type | Applicant |
|---|---|---|
| NDA 212641 | NDA | AQUESTIVE |
| NDA 218623 | NDA | AQUESTIVE |
Marketed products (12)
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT
- LIBERVANT